CLOV vs MANH · rev $1.37B vs P/E 57, rev $1.04B
Clover Health Investments Corp (CLOV) versus Manhattan Associates Inc (MANH) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Manhattan Associates Inc (MANH) is a software - application company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MANH revenue for 2024-12-31 was $1.04B. Net income was $218.4M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. MANH currently screens at market cap $12.14B and trailing P/E 57.1.
CLOV currently screens at market cap $1.55B. MANH currently screens at market cap $12.14B and trailing P/E 57.1.
Not investment advice. Open the CLOV and MANH stock pages for the full models.
Not investment advice.